THPO and neoplasm: The inflammatory state and suppressive tumor microenvironment associated with large and metabolically active tumors can explain the potential impact on hematopoiesis and platelet count recovery, necessitating more frequent use of thrombopoietin agonist and stem cell boost for EMD patients.